4.6 Article

Inclusion of patients with chronic kidney disease in randomized phase 3 clinical trials in patients with prostate, breast, lung, and colorectal cancer

Related references

Note: Only part of the references are listed.
Review Transplantation

The 'other' big complication: how chronic kidney disease impacts on cancer risks and outcomes

Jennifer S. Lees et al.

Summary: Cancer risk is higher in patients with chronic kidney disease (CKD), especially those with lower estimated glomerular filtration rate (eGFR) or albuminuria. The increased risk of cancer in CKD is influenced by various factors including patient characteristics, disease factors, and treatment factors. Renal adverse events associated with chemotherapy and newer anti-cancer therapies may contribute to worse cancer outcomes in CKD patients. Acknowledging the increased cancer risk in CKD can potentially improve management.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2023)

Letter Medicine, General & Internal

Representation of Patients With Chronic Kidney Disease in Trials of Cancer Therapy

Abhijat Kitchlu et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)

Review Medicine, General & Internal

Acute Kidney Injury in Patients with Cancer

Mitchell H. Rosner et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Article Pharmacology & Pharmacy

Pharmacokinetics of Monoclonal Antibodies

Josiah T. Ryman et al.

CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2017)

Article Urology & Nephrology

Cause-Specific Deaths in Non-Dialysis-Dependent CKD

Sankar D. Navaneethan et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)

Article Urology & Nephrology

Onco-Nephrology: Renal Toxicities of Chemotherapeutic Agents

Mark A. Perazella

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)